India, Feb. 25 -- American firm Thermo Fisher Scientific Inc. has entered into a definitive agreement with Solventum to acquire its Purification & Filtration business for approximately $4.1 billion in cash.

Solventum's Purification & Filtration business is a leading provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications. The Solventum business operates globally with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, and has approximately 2,500 colleagues. In 2024, Solventum's Purification & Filtration business generated approximately $1 billion of revenue.

Solventum's Purification & Filtration business i...